Medical Updates | Infection Update

MEDICAL UPDATES

Levofloxacin is associated with greater treatment success and lower mortality in pulmonary multidrug-resistant tuberculosis

11 December, 2018

An individual patient data meta-analysis showed greater treatment success and lower mortality with the use of levofloxacin – compared with other second-line drugs – for pulmonary multidrug-resistant tuberculosis (MDR-TB). The...

An individual patient data meta-analysis showed greater treatment success and lower mortality with the use of levofloxacin – compared with other second-line drugs – for pulmonary multidrug-resistant tuberculosis (MDR-TB). The...

Levofloxacin and sitafloxacin regimens effective for Haemophilus influenzae-positive urethritis

28 November, 2018

Both levofloxacin and sitafloxacin regimens – recommended for the treatment of nongonococcal urethritis (NGU) in Japan – were found to be microbiologically effective for Haemophilus influenzae-positive NGU. Urethritis is one...

Both levofloxacin and sitafloxacin regimens – recommended for the treatment of nongonococcal urethritis (NGU) in Japan – were found to be microbiologically effective for Haemophilus influenzae-positive NGU. Urethritis is one...

Levofloxacin as part of antimicrobial therapy for Mycobacterium fortuitum pulmonary infection

13 November, 2018

A multiple antimicrobial therapy including levofloxacin was found to be effective for Mycobacterium fortuitum pulmonary infection in a patient who did not respond to antibiotics against common pneumonia pathogens....

A multiple antimicrobial therapy including levofloxacin was found to be effective for Mycobacterium fortuitum pulmonary infection in a patient who did not respond to antibiotics against common pneumonia pathogens....

Levofloxacin for extended-spectrum beta-lactamase- (ESBL-) producing Enterobacteriaceae infections

09 November, 2018

Levofloxacin is shown to be a treatment of choice for hospitalised patients with extended-spectrum beta-lactamase- (ESBL-) producing Enterobacteriaceae infections. ESBL is an enzyme that confers resistance to most beta-lactam antibiotics,...

Levofloxacin is shown to be a treatment of choice for hospitalised patients with extended-spectrum beta-lactamase- (ESBL-) producing Enterobacteriaceae infections. ESBL is an enzyme that confers resistance to most beta-lactam antibiotics,...

Sequential doxycycline-sitafloxacin regimen for the treatment of Mycoplasma genitalium infections

18 October, 2018

Initial treatment with doxycycline for non-gonococcal urethritis (NGU) caused by Mycoplasma genitalium followed by resistance-guided therapy of sitafloxacin has been shown to be effective for infections in a population with...

Initial treatment with doxycycline for non-gonococcal urethritis (NGU) caused by Mycoplasma genitalium followed by resistance-guided therapy of sitafloxacin has been shown to be effective for infections in a population with...

Levofloxacin resolves Stenotrophomonas maltophilia pneumonia

12 October, 2018

Antibiotic treatment with levofloxacin (500 mg/day) is shown to be effective in resolving persistent productive cough in a patient with Stenotrophomonas maltophilia pneumonia. A 61-year-old male presented with persistent productive...

Antibiotic treatment with levofloxacin (500 mg/day) is shown to be effective in resolving persistent productive cough in a patient with Stenotrophomonas maltophilia pneumonia. A 61-year-old male presented with persistent productive...

Intravenous piperacillin-tazobactam and levofloxacin for Kocuria kristinae bacteraemic empyema

04 October, 2018

This is the first reported case of community-acquired Kocuria kristinae bacteraemic empyema – resolved after insertion of a chest tube and intravenous piperacillin-tazobactam and levofloxacin. A 57-year-old man presented with...

This is the first reported case of community-acquired Kocuria kristinae bacteraemic empyema – resolved after insertion of a chest tube and intravenous piperacillin-tazobactam and levofloxacin. A 57-year-old man presented with...

Oral levofloxacin and sitafloxacin are effective for the treatment of epididymitis

19 September, 2018

Pharmacokinetics study on oral levofloxacin (500 mg) and sitafloxacin (100 mg) conducted at the Okoyama University Hospital and its related institutions in Japan demonstrated efficacy for the treatment of epididymitis....

Pharmacokinetics study on oral levofloxacin (500 mg) and sitafloxacin (100 mg) conducted at the Okoyama University Hospital and its related institutions in Japan demonstrated efficacy for the treatment of epididymitis....

Levofloxacin: One of the most effective antibiotic for empiric therapy of dacryocystitis

13 September, 2018

Sensitivity data from a retrospective study investigating the microbiologic profile and antibiogram of patients with acute and chronic dacryocystitis demonstrated levofloxacin as one of the most effective empiric antimicrobial therapy...

Sensitivity data from a retrospective study investigating the microbiologic profile and antibiogram of patients with acute and chronic dacryocystitis demonstrated levofloxacin as one of the most effective empiric antimicrobial therapy...

Secondary switch to oral levofloxacin allowed early rehabilitation in primary ventriculitis caused by Neisseria meningitidis

06 September, 2018

A four-week antibiotic regimen combining two weeks of intravenous cefotaxime followed by two weeks of oral levofloxacin was shown to be effective in the treatment of meningococcal ventriculitis in an...

A four-week antibiotic regimen combining two weeks of intravenous cefotaxime followed by two weeks of oral levofloxacin was shown to be effective in the treatment of meningococcal ventriculitis in an...

POPULAR ARTICLES